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http://dx
334Objective: Children who undergo cardiac surgery are at high risk for renal insufficiency and abdominal com-
partment syndrome. Peritoneal dialysis catheter (PDC) implantation is used in this population for abdominal de-
compression and access for dialysis. However, there is no consensus regarding PDC use, and the practice varies
widely. This study was undertaken to assess associated factors, outcomes, and variability in the use of PDC in
patients who have undergone cardiac surgery.
Methods: The cohort was obtained from the Kids’ Inpatient Database, years 2006 and 2009. Patients who un-
derwent cardiac surgery were included and the subset that underwent PDC implantation during the same hos-
pitalization was identified. Univariable and multivariable analyses assessed factors associated with PDC and
survival.
Results: A cohort of 28,259 patients underwent cardiac surgery, of whom 558 (2%) had PDCs placed. In the
PDC group, 39.1% (n¼ 218) had acute renal failure whereas 3.5% or patients (n¼ 974) in the non-PDC group
had acute renal failure. Among patients receiving PDC, mortality was 20.3% (n ¼ 113; vs 3.4% overall mor-
tality, n ¼ 955). Excluding patients with acute renal failure, mortality remained 12% (n ¼ 41) for the PDC
group. Factors associated significantly with PDC placement in the overall cohort were younger age, greater
surgical complexity, nonelective admission, hospital region, use of cardiopulmonary bypass, and acute renal
failure.
Conclusions: Patients receiving PDC after cardiac surgery had 20% mortality, which remained 12% after ex-
cluding patients with acute renal failure. Given the variability in PDC use and poor outcomes, further research is
needed to assess the possible benefit of earlier intervention for peritoneal access in this high-risk cohort.
(J Thorac Cardiovasc Surg 2013;146:334-8)Children who undergo cardiac surgery are at risk for venous
hypertension and low systemicperfusion,whichmaycontrib-
ute to the development of ascites, abdominal compartment
syndrome, decreased renal perfusion, and renal insufficiency.
Renal insufficiency, which affects less than 10% of children
who undergo cardiopulmonary bypass (CPB), worsens fluid
overload and extravasation further.1-3 The catheter may
function to decompress a hypertensive peritoneal cavity4 or
to alleviate the burden of renal insufficiency.5 Allowing
drainage of fluid is hypothesized to alleviate local renal com-
pression and hasten the return of renal function, including via
the removal of proinflammatory cytokines.1,6 Themajority of
the time, permanent peritoneal access is used solely for fluid
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The Journal of Thoracic and Cardiovascular SurgIt remains unknownwhether permanent peritoneal access
confers a clinical benefit. Information on outcomes for pe-
diatric patients who undergo peritoneal dialysis catheter
(PDC) placement after cardiac surgery is lacking. A system-
atic evaluation has been difficult to conduct in this popula-
tion because of the uniqueness of the patient cohort that
undergoes cardiac surgery and goes on to receive a PDC.
In addition, the practice is not standardized. Some surgeons
advocate the use of early prophylactic PDCs in the majority
of postcardiac surgery patients whereas others take the ap-
proach of active monitoring.8 It is equally unclear whether
the benefit of PDCs lies in true peritoneal dialysis or in de-
compression for abdominal compartment syndrome, in
which case temporary access may be less invasive and
equally beneficial. The current study uses the Healthcare
Cost and Utilization Project Kids’ Inpatient Database
(KID) to characterize associated factors, outcomes, and var-
iability in the use of PDCs in patients who have undergone
cardiac surgery.METHODS
Data Source
The KID, created by the Agency for Healthcare Research and Quality,
was used to conduct this study. The KID was developed as part of the
Healthcare Cost and Utilization Project, which is a federal–state–industryery c August 2013
Abbreviations and Acronyms
ARF ¼ acute renal failure
CPB ¼ cardiopulmonary bypass
ICD-9-CM ¼ International Classification of
Diseases, 9th revision, clinical
modification
KID ¼ Kids’ Inpatient Database
PDC ¼ peritoneal dialysis catheter
RACHS-1 ¼ Risk Adjustment for Congenital
Heart Surgery
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Dpartnership, and contains information regarding diagnoses, procedures, pa-
tient demographics, payment source, total charges, and hospital character-
istics. The database samples randomly and systematically 10% of
uncomplicated in-hospital births and 80% of admissions for pediatric pa-
tients (age< 21 years). The KID is released every 3 years, and for this
study, the most recent 2 editions (2006 and 2009) were used. Up to 15 di-
agnoses and 15 procedures are included in the 2006 KID whereas up to 25
diagnoses and 15 procedures are included in the 2009 KID.
All patients who underwent cardiac surgery were included, as assessed
by the International Classification of Diseases, 9th revision, clinical modi-
fication (ICD-9-CM) procedure and diagnosis codes. To identify PDC
placement, the ICD-9-CM code 54.93 (Creation of cutaneoperitoneal fis-
tula) was used. To assess severity of congenital cardiac disease, the Risk
Adjustment for Congenital Heart Surgery (RACHS-1) category was evalu-
ated based on ICD-9-CM procedure codes.9,10 A RACHS-1 risk score of 1
entails the lowest risk category whereas a risk score of 6 entails the highest
risk category. In the event that a patient was able to be grouped into 2 or
more RACHS-1 categories, the highest risk score was selected. The
RACHS-1 adjustment also takes into account age at the time of cardiac op-
eration, prematurity, presence of major noncardiac structural anomaly, and
multiple cardiac procedures. Categories 1 and 2, and 5 and 6 of the RACHS-
1 were combined to preclude reporting<11 observations in any given cell,
in accordance with the with the Agency for Healthcare Research and Qual-
ity data use agreement. If a RACHS-1 category was unable to be assigned
(eg, patients undergoing heart transplantation), patients were classified as
unassigned. Patients who underwent CPB were identified using ICD-9-
CMcode 39.61 (Extracorporeal circulation auxiliary to open heart surgery).
Patients who developed acute renal failure (ARF) were identified by the
ICD-9-CM diagnostic codes 584.9 (Acute renal failure, unspecified), 586
(Renal failure, unspecified), and 639.3 (Renal failure). Peritoneal dialysis
was identified by the ICD-9-CMprocedure code 54.98 (Peritoneal dialysis).
Statistical Analysis
We tabulated patient demographics, hospitalization characteristics,
clinical data, and survival for the patient cohort based on weighted esti-
mates that account appropriately for the KID sampling methodology. Re-
ported percentages are based on available data for each variable. We
assessed univariable associations with PDC using the Rao-Scott c2 test sta-
tistic. Next, adjusted odds ratios for PDC use were obtained from
a weighted multivariable logistic regression model. To evaluate the use
of PDCs for nonrenal failure indications, a multivariable analysis for
PDC use was performed for the subcohort of patients without ARF. The re-
lationship of clinical and health services factors with mortality in the over-
all cohort was then assessed in a multivariable model. Stepwise selection
was used in all multivariable analyses. Patients with missing data were ex-
cluded from each respective univariable and multivariable analysis. An al-
pha level of 5% was considered statistically significant. All data were
analyzed using SAS 9.3 (SAS Institute, Inc, Cary, NC).The Journal of Thoracic and CaRESULTS
Overall Characteristics
Baseline characteristics of the KID patients included
for analysis are reported in Table 1. A total 28,259 cardiac
surgery cases were identified. There were an approximately
equal proportion of male (54.8%, n¼ 15,446) and female as
well as white (51.5%, n ¼ 11,994) and nonwhite patients.
The distribution of RACHS-1 categories was 37.7%
(n ¼ 10,646) in categories 1 and 2, 30.1% (n ¼ 8502)
in category 3, 7.8% (n ¼ 2204) in category 4, and 2.2%
(n ¼ 621) in categories 5 and 6. There were 22.2% of pa-
tients (n ¼ 6286) who were unable to be assigned
a RACHS-1 category. There were 4.2% of patients
(n ¼ 1192) who were diagnosed with ARF, which carried
a mortality rate of 23.7% (n ¼ 282). Most admissions
were elective (59.9%, n ¼ 16,930).
In this cohort, 2% (n¼ 558) of patients had a PDCplaced-
during the same hospitalization.Overallmortalitywas 3.4%
(n¼ 955). Among patients who underwent PDC placement,
mortality was 20.3% (n¼ 113); 39.1% of patients (n¼ 218)
who underwent PDC placement were diagnosed with
ARF. Of the patients who received a PDC, a minority under-
went peritoneal dialysis (21.3%, n ¼ 119). Forty-two pa-
tients in the non-PDC group (0.15%) underwent
peritoneal dialysis via a preexisting catheter that was not
placed during the same hospitalization as the cardiac sur-
gery. Somepatients (0.6%, n¼ 182) underwent paracentesis
without the implantation of permanent peritoneal access.Factors Associated With PDC Use
In the unadjusted analysis, factors associated with
PDC use included age group (P<.01), RACHS-1 category
(P<.01), nonelective admission (P<.01), hospital region
(P<.01), insurance status (P ¼ .02), and ARF (P<.01).
Other univariable associations are reported in Table 1. To
control for confounding, we next performed a multivariable
stepwise regression analysis. Younger age, higher RACHS-
1 category, nonelective admission, South or West hospital
region, CPB, and ARF were associated significantly with
PDC use. Table 2 reports the adjusted odds ratios for the fac-
tors associated with PDC use. In addition, we evaluated the
use of PDCs for nonrenal failure indications. Factors asso-
ciated significantly with PDC use in the subset of patients
without ARF included younger age, higher RACHS-1 cate-
gory, nonelective admission, South or West hospital region,
and CPB. The adjusted odds ratios were similar to those of
the overall cohort, as reported in Table 3.Outcome
Mortality in the group of patients who received PDCs
was 20.3% (n ¼ 113), compared with 3.0% (n ¼ 842)
for patients did not receive PDCs. Mortality rates for pa-
tients with PDCs who had ARF and did not have ARFrdiovascular Surgery c Volume 146, Number 2 335
TABLE 1. Baseline characteristics and outcomes for patients who did
or did not undergo peritoneal dialysis catheter implantation
Variable
Overall,
n (%)
PDC,
n (%)
No PDC,
n (%)
P
value
Sample size 28,259 (100) 558 (2.0) 27,701 (98.0)
Female sex (n ¼ 28,186) 12,740 (45.2) 248 (44.4) 12,492 (45.2) .74
Age group (n ¼ 24,813) <.01
0 to 30 d 6169 (24.9) 206 (59.0) 5963 (24.4)
1 mo to 1 y 6982 (28.1) 69 (19.8) 6913 (28.3)
1 y to 18 y 11,662 (47.0) 74 (21.2) 11,588 (47.4)
White race (n ¼ 23,289) 11,994 (51.5) 236 (47.1) 11,758 (51.6) .40
RACHS-1 category <.01
1 to 2 10,646 (37.7) 77 (13.8) 10,569 (38.1)
3 8502 (30.1) 187 (33.5) 8315 (30.0)
4 2204 (7.8) 116 (20.8) 2088 (7.5)
5 to 6 621 (2.2) 54 (9.7) 567 (2.0)
Unassigned 6286 (22.2) 124 (22.2) 6162 (22.2)
Nonelective admission 11,329 (40.3) 428 (76.8) 10,901 (39.5) <.01
Hospital region <.01
Northeast 4346 (15.4) 14 (2.5) 4332 (15.6)
Midwest 6498 (23.0) 71 (12.7) 6427 (23.2)
South 9710 (34.4) 364 (65.2) 9346 (33.7)
West 7705 (27.3) 109 (19.5) 7596 (27.4)
Teaching hospital
(n ¼ 25,917)
24,544 (94.7) 423 (96.8) 24,121 (94.7) .34
Insurance (n ¼ 28,239) .02
Private 13,120 (46.5) 243 (43.5) 12,877 (46.5)
Medicaid 12,640 (44.7) 282 (50.5) 12,358 (44.6)
Other 2479 (8.8) 33 (5.9) 2446 (8.8)
CPB 21,002 (74.3) 429 (76.9) 20,573 (74.3) .63
ARF 1192 (4.2) 218 (39.1) 974 (3.5) <.01
Died 955 (3.4) 113 (20.3) 842 (3.0) <.01
PDC, Peritoneal dialysis catheter; RACHS-1, risk adjustment for congenital heart
surgery; CPB, cardiopulmonary bypass; ARF, acute renal failure.
TABLE 2. Multivariable stepwise analysis of the factors associated
with peritoneal dialysis catheter use
Variable
Adjusted
odds ratio
95% Confidence
interval
P
value
Age group (vs 30 d)
1 mo to 1 y 0.61 0.33-1.12 .11
1 y to 18 y 0.30 0.18-0.51 <.01
RACHS-1 category (vs 1-2)
3 1.72 1.28-2.32 <.01
4 2.74 1.76-4.26 <.01
5-6 2.74 1.35-5.56 <.01
Unassigned 0.89 0.49-1.63 .70
Nonelective admission 3.11 1.18-8.19 .02
Hospital region (vs Northeast)
Midwest 2.10 0.71-6.18 .17
South 19.35 4.33-88.19 <.01
West 4.11 1.47-11.53 <.01
CPB 2.35 1.10-5.02 .03
ARF 13.15 7.43-23.28 <.01
Stepwise model included sex, age group, race, RACHS-1 category, elective admis-
sion, hospital region, teaching hospital, insurance status, CPB, and ARF. RACHS-1,
Risk adjustment for congenital heart surgery; CPB, cardiopulmonary bypass;
ARF, acute renal failure.
TABLE 3. Multivariable stepwise analysis of the factors associated
with peritoneal dialysis catheter use among patients without acute
renal failure
Variable
Adjusted
odds ratio
95% Confidence
interval
P
value
Age group (vs  30 d)
1 mo to 1 y 0.49 0.26-0.91 .02
1 to 18 y 0.18 0.09-0.34 <.01
RACHS-1 category (vs 1-2)
3 1.78 1.32-2.40 <.01
4 2.09 1.20-3.63 <.01
5 to 6 3.44 1.63-7.27 <.01
Unassigned 1.21 0.63-2.32 .58
Nonelective admission 3.76 1.38-10.21 <.01
Hospital region (vs Northeast)
Midwest 2.99 0.96-9.32 .06
South 48.59 14.05-168.05 <.01
West 6.93 2.90-16.56 <.01
CPB 4.64 2.01-10.69 <.01
Stepwise model included sex, age group, race, RACHS-1 category, elective admis-
sion, hospital region, teaching hospital, insurance status, and CPB. RACHS-1, Risk
adjustment for congenital heart surgery; CPB, cardiopulmonary bypass.
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shown in Table 4. We performed a multivariable analysis of
mortality, which is displayed in Table 5. Placement of
a PDC was not included in the model to avoid confounding
by indication. Variables associated significantly with mor-
tality included younger age group, RACHS-1 category, non-
elective admission, nonprivate insurance, and ARF.
Hospital region was not associated with mortality.
DISCUSSION
The mortality for patients who had PDCs implanted after
cardiac surgery was 20%. Excluding patients with ARF
from the analysis, mortality for the PDC group remained
12%. Factors associated significantly with PDC placement
included younger age, greater surgical complexity, nonelec-
tive admission, South or West hospital region, CPB, and
ARF. Based on the variability observed in this study, the de-
cision to implant PDCs is not standardized. It is possible
that earlier, prophylactic intervention with a PDC may con-
fer a mortality benefit in the appropriate cohort of patients.
Demographic (young age), clinical (CPB and ARF), and336 The Journal of Thoracic and Cardiovascular Surgsystems (nonelective admission) factors were found to be
associated with PDC use in our study. These associations
may be useful in selecting patients in whom to perform
early PDC placement. Neonatal age was associated with
a 2- to 5-fold increase in PDC use in our study. Furthermore,
age has been shown to be an independent risk factor for
postoperative ARF11 and mortality.12 As such, some high-
risk young patients may benefit from prophylactic PDCs.
Presence and severity of ARF are likewise associated with
postoperative mortality.13 In our study, ARF carried anery c August 2013
TABLE 4. Mortality stratified by ARF and PDC groups
Variable
ARF No ARF
PDC No PDC P value PDC No PDC P value
Sample size 218 974 340 26,727
Died (%) 72 (33.0) 210 (21.6) .13 41 (12.1) 632 (2.4) <.01
ARF, Acute renal failure; PDC, peritoneal dialysis catheter.
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nal injury in this patient population is often CPB.14-16 Acute
renal failure has been shown to be 7 times more likely with
CPB time>2 hours.14 Nearly 75% of the patients in our co-
hort underwent CPB. Shorter time to starting peritoneal di-
alysis after ARF has been found to be associated with
increased postoperative survival after congenital cardiac
surgery.17,18 The timing of PDC implantation relative to
serum markers of renal function will fill an important
knowledge gap in the management of cardiac surgery
patients.
The elevated mortality rate of the cohort who received
PDCs may be related to the indications for PDC place-
ment—namely, ARF and intra-abdominal hypertension. Pa-
tients who develop these conditions after cardiac surgery
are known to fare worse than their counterparts who are
not afflicted with these pathophysiologies.17,19 This
argument may be supported by our finding that, limited to
patients without ARF, the mortality rate for the PDC
cohort was attenuated from 20% to 12%. We were not
able to assess the presence of intra-abdominal hypertension.
The association of nonelective admission with increased
PDC use and mortality in our study may reflect a lack of
response to outpatient management or postoperative physi-
ologic decompensation. Not surprisingly, the most common
reason for the readmission of patients with congenital heartTABLE 5. Multivariable stepwise analysis of the factors associated
with mortality
Variable
Adjusted
odds ratio
95% Confidence
interval
P
value
Age group
1 mo to 1 y (vs 30 d) 0.50 0.37-0.69 <.01
1 to 18 y (vs 30 d) 0.26 0.19-0.36 <.01
RACHS-1 category
3 (vs 1-2) 2.15 1.65-2.80 <.01
4 (vs 1-2) 3.21 2.25-4.58 <.01
5 to 6 (vs 1-2) 4.03 2.50-6.50 <.01
Unassigned 3.18 2.27-4.47 <.01
Nonelective admission 2.63 2.00-3.47 <.01
Insurance
Medicaid (vs private) 1.35 1.10-1.66 <.01
Other 1.35 0.93-1.95 .12
ARF 7.18 5.42-9.52 <.01
Stepwise model included sex, age group, race, RACHS-1 category, elective admis-
sion, hospital region, teaching hospital, insurance status, cardiopulmonary bypass,
and ARF. RACHS-1, Risk adjustment for congenital heart surgery; ARF, acute renal
failure.
The Journal of Thoracic and Cadisease has been shown to be exacerbation of cardiac ill-
ness.20 In our study, patients who were admitted as an emer-
gency and underwent cardiac surgery were at high risk for
PDC and mortality. Emergency surgery is known to carry
higher morbidity and mortality rates and poorer long-term
outcomes.21 Previous research has focused on developing
risk scores for patients undergoing nonelective surgery;
however, after the highest risk patients have been identified,
the appropriate intervention is often unclear.22 Given the 3-
fold increased use of a PDC in patients who were admitted
as an emergency in this study, 1 intervention that should be
studied further is lowering the threshold to use PDCs for this
cohort.
We found>60% of PDCs placed in the absence of ARF.
Mortality remained substantial at 12%. Concern for ab-
dominal compartment syndrome may have led to the PDC
implantation in many of these patients, although literature
on the incidence rates of PDC placement for indications
other than renal replacement therapy is nonexistent. In
patients with abdominal compartment syndrome, early es-
tablishment of peritoneal access may improve outcome;
however, it is unclear whether PDC placement was a marker
of disease or a therapeutic tool in our study.
Itwill also be useful to study the comparative effectiveness
between PDCs and temporary peritoneal drains. The compli-
cation rate for the former is not insignificant, considering
that the rate of peritonitis is 1 episode per 11.8months in chil-
dren<2 years who undergo PDC placement.23 For patients
with ARF, temporary peritoneal access may be equally ben-
eficial without the associated risks of a permanent catheter.
Ultimately, these findings suggest the need for a more ro-
bust set of guidelines for peritoneal access in patients who
have recently undergone cardiac surgery. If clinical factors
such as those identified in this study were able to identify
characteristics associated with high risk of PDC placement,
prophylactic intervention may be beneficial for patients pre-
dicted to need PDCs. Extra measures may need to be taken
for this at-risk cohort. Such interventions could take the
form of prophylactic or early PDC placement or a more de-
finitive treatment in decompressive laparotomy.
Limitations
There are several limitations to these results. First, the
study was limited by its retrospective cohort design with
its inherent risk of confounding and bias. Second, by relying
solely on data from the KID, bias could be introduced. The
KID data were not collected specifically for the study of
PDC use among patients after cardiac surgery, so important
covariates may not have been included in the analysis.
Granular clinical data such as the indication for and setting
of (eg, intraoperative or bedside) PDC placement were un-
able to be ascertained. Likewise, data on important perito-
neal dialysis characteristics such as concentrations, dwell
times, and volumes were unable to be attained. We wererdiovascular Surgery c Volume 146, Number 2 337
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diac surgery. Because the KID is an administrative data-
base, there may be patients who underwent cardiac
surgery or PDC placement who were not captured by proce-
dure codes because of omission or miscoding. Given the
multicenter nature of the data set, there was no control
over variation in individual physician practices. Last, the
KID relies on hospital discharge information and foregoes
tracking of readmissions for a given patient. As such, the
current study was unable to capture patients who underwent
PDC placement after hospital discharge. This type of mis-
classification would likely be nondifferential and would
therefore bias the result toward the null.
Despite the inherent limitations of using an administra-
tive database such as the KID, this design does have several
advantages. Foremost, the KID allows a large sample size
for the relatively rare procedure of PDC placement in pa-
tients status postcardiac surgery. In addition, the KID pres-
ents a patient population sample that is captured randomly
and systematically from the national population.
CONCLUSIONS
In conclusion, patients receiving PDCs after cardiac sur-
gery are a high-risk population, with a 20% mortality rate.
Younger age at operation, greater surgical complexity, non-
elective admission, hospital region, and ARF were associ-
ated with PDC placement. Prospective clinical studies are
needed to characterize more completely the indications,
risks, and benefits of PDC placement in patients who have
recently undergone cardiac surgery. Development of
evidence-based practices for PDC placement in patients
who have undergone cardiac surgery may be useful, given
the substantial mortality rate in this population.
References
1. Kist-van Holthe tot Echten JE, Goedvolk CA, Doornaar MB, van der Vorst MM,
Bosman-Vermeeren JM, Brand R, et al. Acute renal insufficiency and renal re-
placement therapy after pediatric cardiopulmonary bypass surgery. Pediatr Car-
diol. 2001;22:321-6.
2. Pedersen KR, Hjortdal VE, Christensen S, Pedersen J, Hjortholm K, Larsen SH,
et al. Clinical outcome in children with acute renal failure treated with peritoneal
dialysis after surgery for congenital heart disease. Kidney Int Suppl. 2008;108:
S81-6.
3. Stromberg D, Fraser CD Jr, Sorof JM, Drescher K, Feltes TF. Peritoneal dialysis:
an adjunct to pediatric postcardiotomy fluid management. Tex Heart Inst J. 1997;
24:269-77.338 The Journal of Thoracic and Cardiovascular Surg4. Sugrue M. Abdominal compartment syndrome. Curr Opin Crit Care. 2005;11:
333-8.
5. Ash SR. Chronic peritoneal dialysis catheters: overview of design, placement,
and removal procedures. Semin Dial. 2003;16:323-34.
6. Dittrich S, Aktuerk D, Seitz S, Mehwald P, Schulte-Monting J, Schlensak C, et al.
Effects of ultrafiltration and peritoneal dialysis on proinflammatory cytokines
during cardiopulmonary bypass surgery in newborns and infants. Eur J Cardio-
thorac Surg. 2004;25:935-40.
7. Alkan T, Akcevin A, Turkoglu H, Paker T, Sasmazel A, Bayer V, et al. Postop-
erative prophylactic peritoneal dialysis in neonates and infants after complex
congenital cardiac surgery. ASAIO J. 2006;52:693-7.
8. Sorof JM, Stromberg D, Brewer ED, Feltes TF, Fraser CD Jr. Early initiation of
peritoneal dialysis after surgical repair of congenital heart disease. Pediatr Neph-
rol. 1999;13:641-5.
9. Jenkins KJ, Gauvreau K, Newburger JW, Spray TL, Moller JH, Iezzoni LI. Con-
sensus-based method for risk adjustment for surgery for congenital heart disease.
J Thorac Cardiovasc Surg. 2002;123:110-8.
10. Jenkins KJ, Gauvreau K. Center-specific differences in mortality: preliminary
analyses using the Risk Adjustment in Congenital Heart Surgery (RACHS-1)
method. J Thorac Cardiovasc Surg. 2002;124:97-104.
11. Sethi SK, Goyal D, Yadav DK, Shukla U, Kajala PL, Gupta VK, et al. Predictors
of acute kidney injury postcardiopulmonary bypass in children. Clin Exp Neph-
rol. 2011;15:529-34.
12. Chang RK, Rodriguez S, Lee M, Klitzner TS. Risk factors for deaths occurring
within 30 days and 1 year after hospital discharge for cardiac surgery among pe-
diatric patients. Am Heart J. 2006;152:386-93.
13. Blinder JJ, Goldstein SL, Lee VV, Baycroft A, Fraser CD, Nelson D, et al.
Congenital heart surgery in infants: effects of acute kidney injury on outcomes.
J Thorac Cardiovasc Surg. 2012;143:368-74.
14. Rodrigues AJ, Evora PR, Bassetto S, Alves L Jr, Scorzoni Filho A, Vicente WV.
Risk factors for acute renal failure after heart surgery. Rev Bras Cir Cardiovasc.
2009;24:441-6.
15. Bahar I, Akgul A, Ozatik MA, Vural KM, Demirbag AE, Boran M, et al. Acute
renal failure following open heart surgery: risk factors and prognosis. Perfusion.
2005;20:317-22.
16. Baskin E, Gulleroglu KS, Saygili A, Aslamaci S, Varan B, Tokel K. Peritoneal
dialysis requirements following open-heart surgery in children with congenital
heart disease. Ren Fail. 2010;32:784-7.
17. Bojan M, Gioanni S, Vouhe PR, Journois D, Pouard P. Early initiation of peri-
toneal dialysis in neonates and infants with acute kidney injury following car-
diac surgery is associated with a significant decrease in mortality. Kidney Int.
2012;82:474-81.
18. Chien JC, Hwang BT,Weng ZC, Meng LC, Lee PC. Peritoneal dialysis in infants
and children after open heart surgery. Pediatr Neonatol. 2009;50:275-9.
19. Pearson EG, Rollins MD, Vogler SA, Mills MK, Lehman EL, Jacques E, et al.
Decompressive laparotomy for abdominal compartment syndrome in children:
before it is too late. J Pediatr Surg. 2010;45:1324-9.
20. Mackie AS, Ionescu-Ittu R, Pilote L, Rahme E, Marelli AJ. Hospital readmis-
sions in children with congenital heart disease: a population-based study. Am
Heart J. 2008;155:577-84.
21. Ascanelli S, Navarra G, Tonini G, Feo C, Zerbinati A, Pozza E, et al. Early and
late outcome after surgery for colorectal cancer: elective versus emergency sur-
gery. Tumori. 2003;89:36-41.
22. Neary WD, Foy C, Heather BP, Earnshaw JJ. Identifying high-risk patients un-
dergoing urgent and emergency surgery. Ann R Coll Surg Engl. 2006;88:151-6.
23. Ronnholm KA, Holmberg C. Peritoneal dialysis in infants. Pediatr Nephrol.
2006;21:751-6.ery c August 2013
